Specify a stock or a cryptocurrency in the search bar to get a summary
Ambu A/S
AMBBYAmbu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark. Address: Baltorpbakken 13, Ballerup, Denmark, 2750
Analytics
WallStreet Target Price
923.87 DKKP/E ratio
75.8876Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures AMBBY
Dividend Analytics AMBBY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
30 %Dividend History AMBBY
Stock Valuation AMBBY
Financials AMBBY
Results | 2019 | Dynamics |